We are Sorry, This Page doesn't Exist
The Zacks Analyst Blog Highlights: Bristol-Myers Squibb, BHP, CVS Health, T-Mobile US and Anthem
Zacks.....»»
Top Analyst Upgrades and Downgrades: Amex, Bristol-Myers, Celgene, Cognizant, EA, Fortinet, Lyft, Target, Tilray, Walmart and More
The top analyst upgrades, downgrades and initiations seen on Friday included American Express, Bristol-Myers Squibb, Celgene, CognizantTechnology Solutions, Electronic Arts, Fortinet, Lyft, Target,........»»
Merck, Bristol-Myers profits rise on cancer drug sales
Merck & Co Inc and Bristol-Myers Squibb Co posted better-than-expected third quarter profit and raised their 2018 earnings forecasts on Thursday due to strong demand for their rival cancer immuno-oncology treatments......»»
The Zacks Analyst Blog Highlights: Roche, Gilead and Bristol Myers (Revised)
For Immediate Releas.....»»
The Zacks Analyst Blog Highlights: Comcast, American Express, Bristol-Myers, T-Mobile and General Motors
Zacks.....»»
Bristol-Myers Squibb acquires Celgene, marrying Opdivo maker with Revlimid maker
Biopharmaceutical giant Bristol-Myers Squibb reached a deal to acquire Celgene, a maker of treatments for cancer and i.....»»
Bristol-Myers Squibb"s Bid To Swallow Celgene Is A Bane For An Overcrowded Oncology Space
Bristol-Myers Squibb"s Bid To Swallow Celgene Is A Bane For An Overcrowded Oncology Space.....»»
Bristol-Myers Squibb to buy Celgene in $74-billion bet on cancer treatments
Bristol-Myers Squibb Co. agreed to acquire Celge.....»»
Gilead Sciences Gets a Boost After Celgene Deal
An analyst upgrade—and renewed interest in biotechs after Bristol-Myers Squibb announced a deal to buy Celgene—have help Gilead’s stock rise......»»
The Zacks Analyst Blog Highlights: Procter & Gamble, NVIDIA, Bristol-Myers, Deere and Ecolab
Zacks.....»»
Peeling Back The Layers: Exploring Bristol-Myers Squibb Through Analyst Insights
Latest Ratings for BMY .....»»
Friday’s Top Analyst Upgrades and Downgrades: Bristol Myers Squibb, Carrier, Comcast, DraftKings, Nvidia, Textron and More
Friday's top analyst upgrades and downgrades included AvalonBay Communities, Bristol-Myers Squibb, Carrier, Comcast, CyrusOne, DraftKings, Nvidia and Textron......»»
Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol Myers reports 5.09% passive stake in iKena Oncology
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Bristol Myers posts $10 billion loss as it books charges relating to MyoKardia and Celgene
Bristol Myers Squibb Co. said Thursday it had a net loss of $10.027.....»»
FDA approves Bristol-Myers combo for metastatic non-small cell lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
Biotech stocks rebounded in the week ended March 6, recovering from the previous week's steep sell-off. The week was light on news flow, barring some smid-cap earnings and COVID-19 treatment and.....»»